Mrv0541 08011313302D 18 19 0 0 1 0 999 V2000 12.2919 -11.1782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.2919 -12.0032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.9931 -12.4156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.7356 -12.0032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.7356 -11.1782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.9931 -10.7657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.5605 -12.0032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.7356 -13.4468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.5605 -13.4468 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 14.1481 -12.7044 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 14.9730 -14.1481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.5605 -11.1782 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 15.3855 -12.0032 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 15.7979 -11.3019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 15.7979 -12.7044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 16.6229 -12.7044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 16.6229 -11.3019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 15.7979 -14.1481 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 8 10 1 0 0 0 0 10 9 1 0 0 0 0 3 4 2 0 0 0 0 9 11 1 6 0 0 0 10 4 1 1 0 0 0 10 7 1 6 0 0 0 4 5 1 0 0 0 0 7 12 2 0 0 0 0 5 6 2 0 0 0 0 7 13 1 0 0 0 0 6 1 1 0 0 0 0 13 14 1 0 0 0 0 13 15 1 0 0 0 0 15 16 1 0 0 0 0 1 2 2 0 0 0 0 14 17 1 0 0 0 0 2 3 1 0 0 0 0 11 18 1 0 0 0 0 8 9 1 0 0 0 0 M END > DB08918 > drugbank > CCN(CC)C(=O)[C@]1(C[C@H]1CN)C1=CC=CC=C1 > InChI=1S/C15H22N2O/c1-3-17(4-2)14(18)15(10-13(15)11-16)12-8-6-5-7-9-12/h5-9,13H,3-4,10-11,16H2,1-2H3/t13-,15+/m0/s1 > GJJFMKBJSRMPLA-DZGCQCFKSA-N > C15H22N2O > 246.348 > 246.173213336 > 2 > 40 > 0.998514729354545 > 28.33919828251937 > 1 > 1 > 0 > 1 > (1S,2R)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide > 1.72 > 1.421706622999999 > -2.30 > 0 > 1 > 2 > 1 > 9.827548067218556 > 46.33 > 73.8095 > 5 > 1 > 1.23e+00 g/l > biotin > 0 > DB08918 > approved; investigational > Levomilnacipran > (1S,2R)-milnacipran; CYCLOPROPANECARBOXAMIDE, 2-(AMINOMETHYL)-N,N-DIETHYL-1-PHENYL-, (1S,2R)-; Levomilnacipran; MILNACIPRAN, (1S,2R)- > Fetzima; Levomilnacipran > Levomilnacipran hydrochloride $$$$